1. Home
  2. REVBW vs MBNKP Comparison

REVBW vs MBNKP Comparison

Compare REVBW & MBNKP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REVBW
  • MBNKP
  • Stock Information
  • Founded
  • REVBW N/A
  • MBNKP N/A
  • Country
  • REVBW United States
  • MBNKP United States
  • Employees
  • REVBW 9
  • MBNKP 128
  • Industry
  • REVBW Biotechnology: Pharmaceutical Preparations
  • MBNKP Commercial Banks
  • Sector
  • REVBW Health Care
  • MBNKP Finance
  • Exchange
  • REVBW Nasdaq
  • MBNKP Nasdaq
  • Market Cap
  • REVBW N/A
  • MBNKP N/A
  • IPO Year
  • REVBW 2020
  • MBNKP 2019
  • Fundamental
  • Price
  • REVBW $0.02
  • MBNKP $25.17
  • Analyst Decision
  • REVBW
  • MBNKP
  • Analyst Count
  • REVBW 0
  • MBNKP 0
  • Target Price
  • REVBW N/A
  • MBNKP N/A
  • AVG Volume (30 Days)
  • REVBW N/A
  • MBNKP N/A
  • Earning Date
  • REVBW N/A
  • MBNKP N/A
  • Dividend Yield
  • REVBW N/A
  • MBNKP N/A
  • EPS Growth
  • REVBW N/A
  • MBNKP N/A
  • EPS
  • REVBW N/A
  • MBNKP N/A
  • Revenue
  • REVBW N/A
  • MBNKP N/A
  • Revenue This Year
  • REVBW N/A
  • MBNKP N/A
  • Revenue Next Year
  • REVBW N/A
  • MBNKP N/A
  • P/E Ratio
  • REVBW N/A
  • MBNKP N/A
  • Revenue Growth
  • REVBW N/A
  • MBNKP N/A
  • 52 Week Low
  • REVBW N/A
  • MBNKP N/A
  • 52 Week High
  • REVBW N/A
  • MBNKP N/A
  • Technical
  • Relative Strength Index (RSI)
  • REVBW N/A
  • MBNKP 45.04
  • Support Level
  • REVBW N/A
  • MBNKP $25.18
  • Resistance Level
  • REVBW N/A
  • MBNKP $25.50
  • Average True Range (ATR)
  • REVBW 0.00
  • MBNKP 0.10
  • MACD
  • REVBW 0.00
  • MBNKP -0.02
  • Stochastic Oscillator
  • REVBW 0.00
  • MBNKP 9.75

About REVBW Revelation Biosciences Inc. Warrant

Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of therapies for the prevention and treatment of disease using trained immunity. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

About MBNKP Medallion Bank Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock Series F

Medallion Bank is engaged in providing consumer loans, raising deposits, and manages other banking activities. It offers affordable financing for home improvement contractors, including window, siding, and roof replacements, kitchen, bath and basement remodels, HVAC (Heating Ventilation and Air Conditioning), and solar PV installations. Medallion also offers recreation financing for new and used motorhomes, towable RVs, truck campers, cargo trailers, utility trailers, horse trailers, and a variety of ATVs and other power sport vehicles. Its segments are Recreation; Home Improvement; and Other. The company generates maximum revenue from the Recreation segment.

Share on Social Networks: